SARS-CoV-2 3CLpro-IN-1
SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a potent inhibitor of SARS-CoV-2 3CLpro. 3CLpro (main coronaviruses cysteine-protease) has been identified as a promising target for the development of antiviral agents. SARS-CoV-2 3CLpro-IN-1 has the potential for the research of infection diseases[1].
Product Specifications
CAS Number
2757970-20-8
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-3clpro-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C(NCCC1=CC=CC(Cl)=C1)C(N(C2=CC=C(C(C)(C)C)C=C2)S(=O)(C=C)=O)C3=CC=CN=C3
Molecular Formula
C27H30ClN3O3S
Molecular Weight
512.06
References & Citations
[1]Stille JK, et al. Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors. Eur J Med Chem. 2022 Feb 5;229:114046.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
